We are live on ! Find out more
PRTA icon

Prothena Corp

201 hedge funds and large institutions have $2.9B invested in Prothena Corp in 2022 Q4 according to their latest regulatory filings, with 44 funds opening new positions, 77 increasing their positions, 51 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

178% more call options, than puts

Call options by funds: $25.7M | Put options by funds: $9.23M

91% more first-time investments, than exits

New positions opened: 44 | Existing positions closed: 23

51% more repeat investments, than reductions

Existing positions increased: 77 | Existing positions reduced: 51

10% more funds holding

Funds holding: 183201 (+18)

7% more capital invested

Capital invested by funds: $2.7B → $2.9B (+$194M)

0.63% more ownership

Funds ownership: 95.03%95.67% (+0.63%)

11% less funds holding in top 10

Funds holding in top 10: 98 (-1)

Holders
201
Holders Change
+18
Holders Change %
+9.84%
% of All Funds
3.23%
Holding in Top 10
8
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-11.11%
% of All Funds
0.13%
New
44
Increased
77
Reduced
51
Closed
23
Calls
$25.7M
Puts
$9.23M
Net Calls
+$16.5M
Net Calls Change
-$11.2M
Name Holding Trade Value Shares
Change
Change in
Stake
Charles Schwab
26
Charles Schwab
California
$18.1M +$885K +15,108 +5%
BC
27
Boxer Capital
California
$18.1M
PA
28
Perceptive Advisors
New York
$14.3M +$448K +7,646 +3%
UBS AM
29
UBS AM
Illinois
$13.8M -$857K -14,642 -6%
Goldman Sachs
30
Goldman Sachs
New York
$13M -$2.96M -50,482 -19%
Millennium Management
31
Millennium Management
New York
$12.9M +$4.93M +84,173 +65%
SCM
32
Suvretta Capital Management
New York
$12.4M -$6.45M -110,083 -35%
Two Sigma Investments
33
Two Sigma Investments
New York
$12.3M +$3.97M +67,750 +50%
GIM
34
Granahan Investment Management
Massachusetts
$12M +$3.44M +58,818 +42%
Morgan Stanley
35
Morgan Stanley
New York
$10.9M +$814K +13,904 +8%
Rafferty Asset Management
36
Rafferty Asset Management
New York
$8.34M +$1.86M +31,687 +30%
PA
37
Pinnacle Associates
New York
$8.29M -$148K -2,525 -2%
Bank of New York Mellon
38
Bank of New York Mellon
New York
$8.25M -$187K -3,195 -2%
FLSM
39
Frazier Life Sciences Management
California
$7.71M +$7.49M +127,900 New
BC
40
Birchview Capital
Vermont
$7.66M +$483K +8,250 +7%
Ensign Peak Advisors
41
Ensign Peak Advisors
Utah
$7.56M +$3.73M +63,665 +103%
WP
42
Woodline Partners
California
$7.45M +$7.24M +123,623 New
Bank of America
43
Bank of America
North Carolina
$7.33M +$2.26M +38,574 +46%
SAM
44
Sectoral Asset Management
Quebec, Canada
$6.94M +$6.75M +115,200 New
ACM
45
Atika Capital Management
New York
$5.49M +$5.34M +91,178 New
UBS Group
46
UBS Group
Switzerland
$5.49M +$4.97M +84,920 +1,381%
TD Asset Management
47
TD Asset Management
Ontario, Canada
$4.91M +$760K +12,974 +19%
Barclays
48
Barclays
United Kingdom
$4.78M +$660K +11,277 +17%
Swiss National Bank
49
Swiss National Bank
Switzerland
$4.78M +$123K +2,100 +3%
SG Americas Securities
50
SG Americas Securities
New York
$4.75M -$3.33M -56,816 -42%

PRTA Hedge Fund Activity: Q4 2022 in Review

201 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Prothena Corp (PRTA) for Q4 2022, worth a combined $2.9B — up 7.2% from $2.7B a quarter earlier.

Buyers outnumbered sellers: 44 funds opened new PRTA positions and 23 closed out — a net gain of 21 holders — while 77 added to existing stakes and 51 trimmed.

The largest buyer was Wellington Management Group, adding an estimated $78.1M. The largest seller was Redmile Group, exiting entirely with an estimated $31.9M sold.

  • 201 institutional investors held Prothena Corp (PRTA) as of Q4 2022, up from 183 in Q3 2022.
  • Funds reported $2.9B of Prothena Corp stock for Q4 2022, up 7.2% quarter-over-quarter.
  • 44 funds opened new Prothena Corp positions in Q4 2022 and 23 closed out, a net change of +21 holders.
  • The largest Prothena Corp buyer in Q4 2022 was Wellington Management Group, an estimated $78.1M added.
  • The largest Prothena Corp seller in Q4 2022 was Redmile Group, an estimated $31.9M sold.

Based on aggregated 13F filings for Q4 2022.